Table 3.
Parameters | N= | % |
---|---|---|
Patients | 100 | 100% |
Controls | 100 | 100% |
Age Group | ||
Age<40 | 22 | 22% |
Age >40 | 78 | 78% |
Stage status | ||
Early (I and II) | 37 | 37% |
Advanced (III and IV) | 63 | 63% |
Grading | ||
Grade I | 14 | 14% |
Grade II | 33 | 33% |
Grade III | 53 | 53% |
Estrogen receptor status | ||
Positive | 67 | 67% |
Negative | 33 | 33% |
Progesterone Receptor status | ||
Positive | 64 | 64% |
Negative | 36 | 36% |
Her2/neu status | ||
Positive | 60 | 60% |
Negative | 40 | 40% |
Distant Metastasis status | ||
Positive | 65 | 65% |
Negative | 35 | 35% |